GC8 allocation letters are the official communications from the Global Fund Secretariat to each eligible country, setting out the funding envelope available for HIV, TB, and malaria programs over the next three-year grant cycle. They represent the starting point for each country's funding request process — defining the financial parameters within which national disease strategies must be designed, and signaling the Global Fund's programmatic priorities and co-financing expectations for each portfolio.

Because the Global Fund does not centrally publish these letters, this tracker depends entirely on civil society partners and country advocates sharing copies as they are received. The aggregate figures and country comparisons shown here reflect only the letters that have been submitted to the Global Advocacy Data Hub. Countries not shown may have received letters that have not yet been shared with us, meaning the portfolio totals below are partial and should be interpreted as indicative, not comprehensive.

The trajectory above is broadly consistent across all three disease components, though the scale of cuts varies. HIV portfolios absorb the largest absolute reductions given their size, while TB programs — already the smallest component in most countries — face proportionally similar cuts.

Country-level variation is considerable — the portfolio average obscures meaningful differences in how cuts are distributed. The chart below breaks down GC7→GC8 funding changes by region, sorted by size of cut.